Erythrodermic psoriasis on the back of a 26 year old female Hispanic patient who has stopped taking the drug Ixekizumab (marketed under the name Taltz) to treat the condition. Psoriasis is an autoimmune disease characterised by patches of abnormal skin. Erythrodermic psoriasis occurs when the rash becomes very widespread, leading to reddened, scaly, thickened patches of skin (caused by excessive skin growth). Ixekizumab is a humanised monoclonal antibody drug that blocks interleukin 17A, which is involved in the inflammatory response.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP29776652
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
yes
Property Release:
Right to Privacy:
No
Same folder images:
Restriction:
Not to be used for advertising or in a defamatory context